Peter Youssef

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Rheumatoid Arthritis

Combination Therapy

Systematic Review

Radical Prostatectomy

Top Venues

Clinical rheumatology

Internal medicine journal

Arthritis & rheumatology (Hoboken, N.J.)

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Natalie Li, Rupert Leong, Peter Youssef
Combination non tumour necrosis factor biologic and small-molecule therapy in a patient with ankylosing spondylitis and Crohn disease. Internal medicine journal 53 (6) (2023)
Matthew Youssef, Peter Youssef
Methotrexate osteopathy. Internal medicine journal 53 (11) (2023)
Adelle S Jee, Iain Stewart, Peter Youssef, Stephen Adelstein, Donna Lai, Sheng Hua, Wendy Stevens, Susanna Proudman, Gene-Siew Ngian, Ian N Glaspole, Yuben P Moodley, Jane F Bleasel, Sacha Macansh, Mandana Nikpour, Joanne Sahhar, Tamera J Corte, null null
A composite serum biomarker index for the diagnosis of systemic sclerosis interstitial lung disease: a multicentre, observational, cohort study. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Claire T Deakin, Geoffrey Owen Littlejohn, Hedley Griffiths, Sabina Ciciriello, Catherine O'Sullivan, Tegan Smith, Peter Youssef, Paul Bird, null null
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings. Internal medicine journal (2023)
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms, Geoff Littlejohn
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset. The Journal of rheumatology 47 (8) (2019)